Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 122.71
+2.96 (2.47%)
Jan 9, 2026, 2:37 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 932.51 million as of January 9, 2026. Its market cap has increased by 14,307.16% in one year.
Market Cap
932.51M
Enterprise Value
849.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
122.71
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 932.51M, an increase of 1,648.39%. That is a compound annual growth rate of 78.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 932.51M | 8.44% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | 53.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.64B |
| Green Thumb Industries | 2.48B |
| dentalcorp Holdings | 2.19B |
| Extendicare | 2.04B |
| Sienna Senior Living | 2.01B |
| Trulieve Cannabis | 1.88B |
| Cronos Group | 1.42B |
| WELL Health Technologies | 1.03B |